ATF4 inhibits TRPV4 function and controls itch perception in rodents and nonhuman primates.
Man-Xiu XieJun-Hua RaoXiao-Yu TianJin-Kun LiuXiao LiZi-Yi ChenYan CaoAn-Nan ChenHai-Hua ShuXiao-Long ZhangPublished in: Pain (2024)
Acute and chronic itch are prevalent and incapacitating, yet the neural mechanisms underlying both acute and chronic itch are just starting to be unraveled. Activated transcription factor 4 (ATF4) belongs to the ATF/CREB transcription factor family and primarily participates in the regulation of gene transcription. Our previous study has demonstrated that ATF4 is expressed in sensory neurons. Nevertheless, the role of ATF4 in itch sensation remains poorly understood. Here, we demonstrate that ATF4 plays a significant role in regulating itch sensation. The absence of ATF4 in dorsal root ganglion (DRG) neurons enhances the itch sensitivity of mice. Overexpression of ATF4 in sensory neurons significantly alleviates the acute and chronic pruritus in mice. Furthermore, ATF4 interacts with the transient receptor potential cation channel subfamily V member 4 (TRPV4) and inhibits its function without altering the expression or membrane trafficking of TRPV4 in sensory neurons. In addition, interference with ATF4 increases the itch sensitivity in nonhuman primates and enhances TRPV4 currents in nonhuman primates DRG neurons; ATF4 and TRPV4 also co-expresses in human sensory neurons. Our data demonstrate that ATF4 controls pruritus by regulating TRPV4 signaling through a nontranscriptional mechanism and identifies a potential new strategy for the treatment of pathological pruritus.
Keyphrases
- transcription factor
- endoplasmic reticulum stress
- spinal cord
- neuropathic pain
- atopic dermatitis
- dna binding
- genome wide identification
- liver failure
- drug induced
- gene expression
- type diabetes
- endothelial cells
- risk assessment
- poor prognosis
- extracorporeal membrane oxygenation
- artificial intelligence
- deep learning
- aortic dissection
- mouse model
- optical coherence tomography
- induced pluripotent stem cells
- replacement therapy